SCHEMBL8796348

SCHEMBL8796348

CC(C)(C)[Si](C)(C)Oc1cc(I)ccc1C1C2CC3CC(C2)CC1C3

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8796050 0.79 CYP3A4 (0.35) SCN9A
SCHEMBL9334077 0.77 NPY1R (0.32)
SCHEMBL8796347 0.75 RARA (0.31)
SCHEMBL16516779 0.70 CYP3A4 (0.37)
SCHEMBL1421446 0.69 DRD2 (0.39)
SCHEMBL3954770 0.67 PREP (0.35)
SCHEMBL8795608 0.67 SCN9A (0.36) SCN9A
SCHEMBL19354829 0.66 SLC6A4 (0.36)
SCHEMBL275754 0.66 ERN1 (0.39)
SCHEMBL8796193 0.64 CXCR3 (0.36) SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0629604-B1 Alicyclic phospholipase A2 inhibitors BRISTOL MYERS SQUIBB CO (US) 1997-04-16 EP disclosed
US-5436369-A Alicyclic phospholipase A2 inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1995-07-25 US disclosed
EP-0629604-A2 Alicyclic phospholipase A2 inhibitors Bristol-Myers Company (US) 1994-12-21 EP disclosed